학술논문
CO108 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Disease Duration and Use of PRIOR Treatment: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Document Type
Abstract
Author
Source
In Value in Health July 2022 25(7) Supplement:S324-S324
Subject
Language
ISSN
1098-3015